Anurag Agarwal
Anurag Agarwal is Co-Founder and CEO at Vedana Therapeutics. He previously founded SCIMALS, a scientific and market due diligence service for life science VCs and angel investors, and has held roles at Osage University Partners and The BALSA Group. His expertise is in biotech and life science investments.
Recent coverage
Front-page news, podcasts and videos about Anurag
Seattle Biotech Vedana Therapeutics Raises $46 Million to Develop Injectable Migraine Treatments
Seattle biotech Vedana Therapeutics raised $46 million in funding to develop injectable migraine treatments and plans to start Phase 1 trials next year under CEO Anurag Agarwal. The company has launched out of stealth mode to pursue its migraine therapy development.
Organizations
See all 6-
Vedana Therapeutics Co-Founder and CEO 2024–present, CEO · current
-
Osage University Partners (OUP) Partner 2023–2024, Principal 2017–2023 · past
-
The Boston Consulting Group Consultant 2014–2017 · past
Education
-
Washington University in St. Louis PhD, Molecular Cell Biology · 2007–2014
-
Indian Institute of Technology, Madras Bachelor of Technology (B.Tech.), Biotechnology with minor in Biomedical Engg. · 2003–2007
-
Indian Institute of Technology, Bombay